Log In
Print
BCIQ
Print
Print this Print this
 

KHK6188

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionCannabinoid CB2 receptor agonist
Molecular Target Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat neuropathic pain associated with previous herpes zoster infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today